Roxithromycin, also known as arrow-roxithromycin, is a semi-synthetic
macrolide antibiotic, which prevents bacterial growth by interfering
with protein synthesis. The drug is indicated to treat certain types
of bacterial infections such as pharyngitis, sinusitis, bronchitis
and pneumonia, urinary and soft tissue infections, and otitis media.
Ask
for In-depth Sample Copy of This Research @
https://www.coherentmarketinsights.com/insight/request-sample/2257
Roxithromycin Market– Driver
Increasing research for new applications of roxithromycin is expected
to propel growth of the roxithromycin market during the forecast
period. For instance, according to a research by Otago University,
New Zealand in July 2018, roxithromycin can be effective in treating
myeloma, a cancer of plasma cells that usually arises in the bone
marrow and is mainly associated with depletion of hemoglobin levels.
The drug aids in increasing hemoglobin levels, which strongly
suggests that the amount of myeloma in bone marrow has reduced.
However, the drug is still under research to confirm its use in
treating myeloma.
Roxithromycin Market– Regional Analysis
On the basis of region, the global roxithromycin market is
segmented into North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa.
North America is expected to hold dominant position in the global
roxithromycin market during the forecast period. This is owing to
increasing government initiatives to prevent antimicrobial resistance
and growing awareness for proper use of antibiotics. For instance in
March 2015, Health Canada released Federal Action Plan with rules to
reduce the risk of antimicrobial resistance in Canada, which includes
infection prevention and control, research and innovation in
developing antibiotics, and appropriate antimicrobial use for health
professionals and the public of Canada.
Asia Pacific is expected to witness significant growth in the global
roxithromycin market during the forecast period. This is owing to
high infectious disease burden, unregulated sales of antibiotics and
poor public health infrastructure, which are leading to increasing
use of antibiotics in economies such as India. For instance,
according to a report published in the journal The Lancet Infectious
Diseases February 2017, Low-Income and Middle-Income Countries
(LMICs) of Asia Pacific such as Nepal, Pakistan, India, and
Bangladesh witness significant demand for roxithromycin, owing to
less stringent policies and easy availability of antibiotics over the
counter.
Key players operating in the global roxithromycin market include,
Hetero Healthcare Ltd., Finecure Pharmaceuticals Ltd., Zhejiang
Zhenyuan Pharmaceutical Co Ltd, Johnson & Johnson Private
Limited, Hygeia Laboratories Inc, Bayer AG, Allergan plc., Galderma
S.A, Valeant Pharmaceutical International, and Stiefel Laboratories
Roxithromycin Market– Taxonomy
By Indication:
-
Urinary and Soft Tissue Infections
-
Respiratory Tract Infections
-
Pneumonia
-
Otitis media
-
Sinusitis
By Distribution Channel:
-
Hospital Pharmacies
-
Retail Pharmacies
-
Online Pharmacies
By Region:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East
-
Africa
For
More Information, Browse Full Report Here:
https://www.coherentmarketinsights.com/ongoing-insight/roxithromycin-market-2257
Also,
Coherent Market Insights has a proprietary database of pipeline
biologics and biosimilars, called PHASE-XS. This database provides
analytical data in addition to the clinical information of ongoing
trials for biologics and biosimilars. An amalgamation of more than 30
parameters, PHASE-XS helps biotechnology and pharmaceutical companies
to analyze the market trend, competition, and market potential. For
more information or to access this database, kindly
click on the below link or contact at
sales@coherentmarketinsights.com
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and
consulting firm offering action-ready syndicated research reports,
custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment